Lamzede® (velmanase alfa-tycv) – New orphan drug approval
February 16, 2023 - Chiesi Global Rare Diseases announced the FDA approval of Lamzede (velmanase alfa-tycv), for the treatment of non-central nervous system manifestations of alpha mannosidosis in adult and pediatric patients.
Download PDF
